State AZ
Clinical Trials in Arizona
Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 249 actively recruiting studies with Arizona sites out of 249 registered in total. The busiest research areas in Arizona are Obesity, Solid Tumor, Overweight. Leading sponsors running trials in the state include AstraZeneca, Mayo Clinic, Eli Lilly and Company. By stage, Arizona trials break down as Phase 1 (35), Phase 2 (81), Phase 3 (85), Phase 4 (9).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Arizona
Frequently Asked Questions — Clinical Trials in Arizona
How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 249 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 249. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Obesity, Solid Tumor, Overweight, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Arizona
NCT06216301 Phase 3
Recruiting
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastati...
Condition
Metastatic Non-small Cell Lung Cancer
Enrollment
734 pts
Location
United States, Austria, Belgium
Sponsor
NovoCure GmbH
NCT03592472 Phase 3
Recruiting
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanc...
Condition
Renal Cell Carcinoma
Enrollment
413 pts
Location
United States, China, Italy
Sponsor
Xynomic Pharmaceuticals, Inc.
NCT05980052 N/A
Recruiting
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
Condition
Physical Activity
Enrollment
144 pts
Location
United States
Sponsor
Arizona State University
NCT07095452 Phase 2, Phase 3
Recruiting
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous...
Condition
Multiple Myeloma
Enrollment
660 pts
Location
United States, France, Japan
Sponsor
AbbVie
NCT06667141 Phase 1
Recruiting
Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
Condition
Specific Advanced Solid Tumors
Enrollment
100 pts
Location
United States
Sponsor
Acrivon Therapeutics
NCT06104566 Phase 3
Recruiting
Global Trial in APG2575 for Patients With CLL/SLL
Condition
CLL/SLL
Enrollment
400 pts
Location
United States, Australia, Belgium
Sponsor
Ascentage Pharma Group Inc.
NCT07051629 Phase 1
Recruiting
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And P...
Condition
Epilepsy
Enrollment
88 pts
Location
United States
Sponsor
Suninflam Inc
NCT06963827 Phase 3
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Condition
Kidney Disease
Enrollment
347 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
NCT05442567 Phase 3
Recruiting
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disea...
Condition
Ulcerative Colitis
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
Takeda
NCT07290036 Phase 1
Recruiting
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Simila...
Condition
Psoriatic Arthritis
Enrollment
392 pts
Location
United States, Bulgaria, Czechia
Sponsor
UCB Biopharma SRL
NCT06866275 Phase 2
Recruiting
Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population ...
Condition
Autism Spectrum Disorder (ASD)
Enrollment
45 pts
Location
United States
Sponsor
Children's Hospital of Orange
NCT06658730 N/A
Recruiting
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With A...
Condition
Vascular Disease
Enrollment
1,500 pts
Location
United States, Denmark, France
Sponsor
W.L.Gore & Associates
NCT07519395 Phase 2
Recruiting
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo...
Condition
Irritable Bowel Syndrome
Enrollment
420 pts
Location
United States
Sponsor
GlaxoSmithKline
NCT06095128 Phase 4
Recruiting
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Condition
Ulcerative Colitis
Enrollment
65 pts
Location
United States, Canada
Sponsor
Takeda
NCT06581432 Phase 2
Recruiting
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanc...
Condition
Solid Tumours
Enrollment
588 pts
Location
United States, Australia, Belgium
Sponsor
Boehringer Ingelheim
NCT07288138 Phase 2
Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicar...
Condition
Metabolic Dysfunction-associated Steatohepatitis
Enrollment
160 pts
Location
United States
Sponsor
Eccogene
NCT05511363 Phase 3
Recruiting
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis As...
Condition
Psychosis Associated With Alzheimer's Disease
Enrollment
410 pts
Location
United States, Bulgaria, Croatia
Sponsor
Karuna Therapeutics, Inc., a B
NCT05658575 Phase 2, Phase 3
Recruiting
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Condition
Acute Gout Flare
Enrollment
300 pts
Location
United States, France, Israel
Sponsor
Olatec Therapeutics, Inc.
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT05701280 N/A
Recruiting
Pilot/Pivotal Study of DBS+Rehab After Stroke
Condition
Stroke
Enrollment
202 pts
Location
United States
Sponsor
Enspire DBS Therapy, Inc.
NCT07325526 Phase 2
Recruiting
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver...
Condition
Liver Cirrhosis
Enrollment
29 pts
Location
United States, Canada
Sponsor
Boehringer Ingelheim
NCT06508463 Phase 1
Recruiting
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lympho...
Condition
Peripheral T Cell Lymphoma
Enrollment
21 pts
Location
United States
Sponsor
Mayo Clinic
NCT07287098 Phase 2
Recruiting
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Recepto...
Condition
Breast Neoplasms
Enrollment
600 pts
Location
United States, Belgium, France
Sponsor
Eli Lilly and Company
NCT06975865 Phase 3
Recruiting
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years Wit...
Condition
Sickle Cell Disease
Enrollment
192 pts
Location
United States, Belgium, Brazil
Sponsor
Sanofi
NCT06237452 Phase 3
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Condition
Clostridium Difficile
Enrollment
852 pts
Location
United States, Australia, Belgium
Sponsor
Vedanta Biosciences, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology